Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-infectious Intermediate Uveitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT01280669
What this trial is testing

Intravitreal Sirolimus as Therapeutic Approach to Uveitis

Who this might be right for
UveitisIntermediate UveitisPosterior Uveitis+1 more
Stanford University
Not applicableStudy completedNCT02916017
What this trial is testing

HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis

Who this might be right for
Uveitis
AbbVie 259
Large-scale testing (Phase 3)Ended earlyNCT02258854
What this trial is testing

An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data

Who this might be right for
Uveitis
XOMA (US) LLC 69
Not applicableStudy completedNCT03339102
What this trial is testing

Post-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis Patients

Who this might be right for
Non-infectious Intermediate, Posterior and Panuveitis
AbbVie 158
Large-scale testing (Phase 3)Ended earlyNCT01095250
What this trial is testing

Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

Who this might be right for
Uveitis
Novartis Pharmaceuticals 30
Large-scale testing (Phase 3)Ended earlyNCT01684345
What this trial is testing

Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis

Who this might be right for
Uveitis
XOMA (US) LLC 200
Early research (Phase 1)Study completedNCT00280826
What this trial is testing

Efalizumab to Treat Uveitis

Who this might be right for
UveitisMacular Edema
National Eye Institute (NEI) 6
Large-scale testing (Phase 3)Looking for participantsNCT05486468
What this trial is testing

The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment

Who this might be right for
UveitisUveitis, PosteriorUveitis, Anterior+1 more
Texas Retina Associates 30
Testing effectiveness (Phase 2)UnknownNCT01717170
What this trial is testing

Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study

Who this might be right for
Intermediate UveitisPosterior UveitisPan-uveitis
University of Nebraska 36
Large-scale testing (Phase 3)WithdrawnNCT01327664
What this trial is testing

Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis

Who this might be right for
Uveitis
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT04706741
What this trial is testing

A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior Uveitis

Who this might be right for
Uveitis
ACELYRIN Inc. 7
Post-approval studies (Phase 4)Study completedNCT00132691
What this trial is testing

Multicenter Uveitis Steroid Treatment (MUST) Trial

Who this might be right for
Uveitis
JHSPH Center for Clinical Trials 255
Testing effectiveness (Phase 2)Ended earlyNCT05384249
What this trial is testing

Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis

Who this might be right for
Uveitis
ACELYRIN Inc. 96
Large-scale testing (Phase 3)Ended earlyNCT01090310
What this trial is testing

Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis

Who this might be right for
Non-infectious Uveitis
Novartis Pharmaceuticals 86
Post-approval studies (Phase 4)UnknownNCT06085079
What this trial is testing

Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study

Who this might be right for
Uveitis, PosteriorUveitis, AnteriorUveitis, Intermediate+1 more
Massachusetts Eye Research and Surgery Institution 20